Maninder Hora, Ph.D.

Vice President, Product and Quality Operations

Dr. Hora has 25 years of drug development experience in the biopharmaceutical and pharmaceutical industry. Dr. Hora served as Vice President, Product Operations, at Facet Biotech’s predecessor, PDL BioPharma, since March 2008 when he assumed responsibilities for process development, product supply and quality functions after the divestiture of PDL's manufacturing facility. He joined PDL as Vice President, Process Development, in July 2006. Before PDL, Dr. Hora was Vice President of Process and Product Development at Chiron Corporation (now Novartis) in Emeryville, California from 2001 to 2006, and held positions of increasing responsibility within Chiron from 1986 to 2001. Since 2001, Dr. Hora has led a large group of scientists and engineers in the design, development and implementation of process, analytics, formulation and device technologies for antibody, protein and small molecule drugs from early preclinical and clinical development to licensure and post-marketing stages. His groups have been instrumental in scaling up dozens of biopharmaceutical processes for phase 3 clinical production, commercial introduction and post-licensure changes. Dr. Hora served as a key member of various teams that successfully registered eight drug or vaccines in the U.S. and Europe during his 20-year tenure at Chiron. Dr. Hora has also held positions at Wyeth Pharmaceuticals and GlaxoSmithKline PLC prior to joining Chiron. Dr. Hora completed his Ph.D. in Bioengineering from the Indian Institute of Technology, Delhi, India and was a Fulbright Scholar at the University of Washington, Seattle prior to joining the industry.